E Fund Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56K | Sell |
32,559
-6,835
| -17% | -$11.8K | ﹤0.01% | 388 |
|
|
2025
Q1 | $131K | Sell |
39,394
-45
| -0.1% | -$150 | 0.01% | 374 |
|
|
2024
Q4 | $292K | Sell |
39,439
-2,513
| -6% | -$18.6K | 0.01% | 319 |
|
|
2024
Q3 | $394K | Buy |
41,952
+1,040
| +3% | +$9.77K | 0.02% | 224 |
|
|
2024
Q2 | $328K | Buy |
40,912
+13,310
| +48% | +$107K | 0.02% | 220 |
|
|
2024
Q1 | $409K | Sell |
27,602
-39,136
| -59% | -$580K | 0.03% | 212 |
|
|
2023
Q4 | $543K | Sell |
66,738
-10,112
| -13% | -$82.2K | 0.03% | 145 |
|
|
2023
Q3 | $350K | Buy |
76,850
+20,241
| +36% | +$92.2K | 0.03% | 190 |
|
|
2023
Q2 | $399K | Sell |
56,609
-5,579
| -9% | -$39.3K | 0.03% | 170 |
|
|
2023
Q1 | $380K | Buy |
62,188
+1,236
| +2% | +$7.55K | 0.03% | 183 |
|
|
2022
Q4 | $389K | Buy |
60,952
+18,421
| +43% | +$118K | 0.03% | 189 |
|
|
2022
Q3 | $407K | Sell |
42,531
-10,224
| -19% | -$97.8K | 0.04% | 180 |
|
|
2022
Q2 | $582K | Buy |
52,755
+32,402
| +159% | +$357K | 0.05% | 121 |
|
|
2022
Q1 | $339K | Buy |
+20,353
| New | +$339K | 0.01% | 171 |
|